5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.76▲ | 2.76▲ | 2.76▲ | 2.86▼ | 3.72▼ |
MA10 | 2.79▲ | 2.79▲ | 2.84▼ | 3.19▼ | 4.72▼ |
MA20 | 2.90▼ | 2.96▼ | 3.02▼ | 3.74▼ | 6.98▼ |
MA50 | 3.47▼ | 3.72▼ | 3.81▼ | 5.28▼ | 18.24▼ |
MA100 | 4.02▼ | 4.09▼ | 4.13▼ | 7.38▼ | 36.57▼ |
MA200 | 4.26▼ | 5.16▼ | 6.00▼ | 15.14▼ | 81.81▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.028▲ | 0.027▲ | 0.013▲ | -0.021▼ | 0.423▲ |
RSI | 38.985▼ | 36.051▼ | 30.726▼ | 28.458▼ | 27.900▼ |
STOCH | 36.843 | 28.261 | 13.956▼ | 10.735▼ | 3.080▼ |
WILL %R | -71.287 | -71.287 | -71.287 | -87.834▼ | -97.395▼ |
CCI | -17.791 | -34.587 | -49.315 | -82.393 | -97.501 |
Wednesday, March 27, 2024 11:43 AM
Lixte (LIXT) stock was up nearly 60% Wednesday after the company reported the publication of positive preclinical data for its lead clinical asset LB-100. Read more here.
|
Tuesday, March 26, 2024 02:21 AM
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has closed on its registered direct offering. The ...
|
Monday, March 25, 2024 05:00 PM
Discover which stocks are splitting, the ratio, and split ex-date with the latest information from EDGAR® Online LLC. Data provided by and © 2024 EDGAR® Online LLC ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
28/03/24 | 2.84 | 2.84 | 2.68 | 2.81 | 4,173 |
27/03/24 | 2.85 | 2.90 | 2.50 | 2.71 | 50,445 |
26/03/24 | 3.01 | 3.01 | 2.70 | 2.74 | 57,381 |
25/03/24 | 3.17 | 3.27 | 2.9335 | 3.00 | 76,447 |
22/03/24 | 3.00 | 3.09 | 2.933 | 3.06 | 25,885 |
21/03/24 | 3.07 | 3.15 | 2.93 | 3.02 | 41,703 |
20/03/24 | 3.24 | 3.3388 | 2.80 | 2.98 | 102,853 |
19/03/24 | 3.82 | 3.84 | 3.405 | 3.42 | 174,287 |
18/03/24 | 4.14 | 4.48 | 4.00 | 4.09 | 54,335 |
15/03/24 | 4.19 | 4.28 | 4.03 | 4.04 | 37,784 |
|
|
||||
|
|
||||
|
|